Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort ascending Project # RFA # PI/Project Leader Institution Title Status
2008 R42 RFA-CA-07-044 SAXENA, SATYA PRAKASH CALIBRANT BIOSYSTEMS, INC. VALIDATION AND QUANTIFICATION OF FFPE ANTIGEN RETRIEVAL BY PROTEOME ANALYSIS Complete
2006 R42 RFA-CA-05-006 BAO, GANG VIVONETICS, INC. IN VIVO GENE DETECTION FOR CANCER ANALYSIS Complete
2002 R42 PAR-99-101 SWENBERG, JAMES A ENO RIVER LABS, LLC ULTRASENSITIVE METHODS FOR HUMAN BIOMARKER QUANTITATION Complete
2004 R42 PAR-01-105 SKIPPER, PAUL L NEWTON SCIENTIFIC, INC. TRITUM AMS ANALYSIS OF CANCER BIOMARKERS Complete
2009 R42 RFA-CA-08-012 GORBOVITSKI, BORIS ADVANCED BIOMEDICAL MACHINES, INC. DATA ACQUISITION SYSTEM FOR MULTIPLEX ANALYSIS OF COLOR ENCODED PARTICLES Complete
2007 R42 RFA-CA-07-011 RAMPERSAUD, ARFAAN COLUMBUS NANOWORKS, INC. COMMERCIALIZATION OF MAGNETIC NANOBEADS FOR CANCER CELL ENRICHMENT Complete
2006 R41 RFA-CA-06-006 HIRSCHOWITZ, EDWARD A 20/20 GENESYSTEMS, INC. AUTO-ANTIBODY PROFILING OF NON-SMALL CELL LUNG CANCER Complete
1999 R41 PAR-98-066 MACH, ROBERT H ANASAZI BIOMEDICAL RESEARCH, INC. SIGMA 1 RECEPTOR PROBES FOR IMAGING TUMOR PROLIFERATION Complete
2001 R41 PAR-99-101 SULK, ROBERTA A DELTANU, LLC ONE STEP H. PYLORI TEST--SCREENING AND INDIVIDUAL ASSAYS Complete
2000 R41 PAR-98-066 SWENBERG, JAMES A ENO RIVER LABS, LLC ULTRASENSITIVE METHODS FOR HUMAN DNA ADDUCT QUANTITATION Complete
2000 R41 PAR-98-066 SKIPPER, PAUL L NEWTON SCIENTIFIC, INC. TRITIUM AMS ANALYSIS OF CANCER BIOMARKERS Complete
2000 R41 PAR-98-066 LIFSHITZ, NADIA BIOPHOTONICS CORPORATION MONOLITHIC MULTI-CAPILLARY ARRAYS TO SEQUENCE DNA Complete
2003 R41 PAR-01-105 SANTANGELO, PHILIP J VIVONETICS, INC. IN VIVO GENE EXPRESSION IMAGING FOR CANCER ANALYSIS Complete
2003 R41 PAR-01-105 GUTHOLD, MARTIN NANOMEDICA, INC. NOVEL, SINGLE-MOLECULE APTAMER SELECTION METHOD Complete
2007 R41 RFA-CA-07-011 CAO, HAN BIONANOMATRIX, INC. CONTINUOUS CHROMOSOME SORTING WITH MICRO/NANOFLUIDICS Complete
2016 R33 RFA-CA-15-003 LIN, QIAO COLUMBIA UNIV NEW YORK MORNINGSIDE Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma NCE
2012 R33 RFA-CA-12-005 LIOTTA, LANCE ALLEN GEORGE MASON UNIVERSITY NANOTRAP TECHNOLOGY FOR ONE STEP PRESERVATION AND AMPLIFICATION OF CANCER BIOMARK Complete
2019 R33 RFA-CA-18-003 DE VLAMINCK, IWIJN CORNELL UNIVERSITY Spatially Resolved Metagenomics to Explore Tumor-Microbiome Interactions in Human Colorectal Cancer Active
2023 R33 RFA-CA-22-004 BRUDNO, YEVGENY NORTH CAROLINA STATE UNIVERSITY RALEIGH MASTER Scaffolds for Rapid, Single-Step Manufacture and Prototyping of CAR-T cells Active
2002 R33 PAR-01-106 SCHNITZER, JAN EUGENIUSZ SIDNEY KIMMEL CANCER CENTER TECHNOLOGY TO UNMASK ACCESSIBLE TUMOR VASCULAR TARGETS Complete
2005 R33 RFA-CA-05-002 SCHWARTZ, DAVID C. UNIVERSITY OF WISCONSIN MADISON SINGLE MOLECULE GENOME ANALYSIS OF OLIGODENDROGLIOMA Complete
2015 R33 RFA-CA-14-004 BORGES, CHAD R ARIZONA STATE UNIVERSITY-TEMPE CAMPUS VALIDATION AND ADVANCED DEVELOPMENT OF GLYCAN NODE ANALYSIS IN LUNG CANCER RESEARCH Complete
2022 R33 CA21-004 LANDAU, DAN WEILL MEDICAL COLL OF CORNELL UNIV Expanding the GoT toolkit to link single-cell clonal genotypes with protein, transcriptomic, epigenomic and spatial phenotypes Active
2010 R33 RFA-CA-09-007 KENIS, PAUL J. A. UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN FRET-BASED BIOSENSORS TO MONITOR REDOX IN CELL CYCLE REGULATION Complete
2014 R33 RFA-CA-13-004 TURESKY, ROBERT J. UNIVERSITY OF MINNESOTA CARCINOGEN DNA ADDUCT BIOMARKERS IN FORMALIN FIXED TISSUES Complete
2017 R33 RFA-CA-16-002 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INST Maximum efficiency sequencing using nuclease-based mutation enrichment and digital barcodes NCE
2021 R33 CA20-018 ZENG, YONG UNIVERSITY OF FLORIDA Integrative Functional Profiling of Tumor-Derived Extracellular Vesicles Complete
2001 R33 PAR-99-100 SIKIC, BRANIMIR I STANFORD UNIVERSITY GENE EXPRESSION PROFILING OF UNKNOWN PRIMARY CANCERS Complete
2013 R33 RFA-CA-12-005 SCHLEGEL, RICHARD GEORGETOWN UNIVERSITY CONDITIONALLY REPROGRAMMED CELLS AS A NOVEL TOOL FOR BIOBANKING Complete
2013 R33 RFA-CA-13-002 KUHN, PETER SCRIPPS RESEARCH INSTITUTE CLINICAL VALIDATION OF THE HD-CTC FLUID BIOPSY IN EARLY DETECTION OF LUNG CANCER. Complete
2019 R33 RFA-CA-18-003 YANG, JENNY J. GEORGIA STATE UNIVERSITY Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment Active
2023 R33 RFA-CA-22-002 KLEIN, ALLON MOSHE HARVARD MEDICAL SCHOOL Micro-capsules for versatile multiplexed cytometry Active
2002 R33 PAR-98-067 CHANCE, MARK R YESHIVA UNIVERSITY DYNAMICS OF MACROMOLECULAR INTERACTIONS Complete
2005 R33 RFA-CA-05-002 BAKER, JAMES R UNIVERSITY OF MICHIGAN AT ANN ARBOR PHOTONIC CRYSTAL FIBER PROBE FLUORESCENCE BIOSENSING Complete
2015 R33 RFA-CA-14-004 MANALIS, SCOTT R MASSACHUSETTS INSTITUTE OF TECHNOLOGY SINGLE CELL GROWTH ASSAY FOR RESIDUAL CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA Complete
2018 R33 RFA-CA-17-013 BORGES, CHAD R ARIZONA STATE UNIVERSITY-TEMPE CAMPUS Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity Active
2022 R33 CA21-004 WANG, TZA-HUEI JEFF JOHNS HOPKINS UNIVERSITY A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies Active
2010 R33 RFA-CA-09-007 ROBINSON, JOSEPH PAUL PURDUE UNIVERSITY SPECIFIC DETECTION OF CERVICAL CANCERS USING CYTOMETRY-BASED MOLECULAR DIAGNOSTIC Complete
2017 R33 RFA-CA-16-002 IBRAHIM, YEHIA BATTELLE PACIFIC NORTHWEST LABORATORIES High Resolution High Throughput Proteomics Platform for Cancer Research NCE
2021 R33 CA20-018 JIANG, NING JENNY UNIVERSITY OF PENNSYLVANIA A streamlined, high-throughput platform for validation of cancer antigen presentation and isolation of cancer antigen reactive T cells Complete
2001 R33 PAR-99-100 TUNG, CHING-HSUAN MASSACHUSETTS GENERAL HOSPITAL IN VIVO IMAGING OF MATRIX METALLOPROTEASE Complete
2013 R33 RFA-CA-13-002 BROWN, BRIAN DAVID ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI SENSOR-SEQ: A GENOME-WIDE BIOLOGICAL MEASURE OF MICRORNA ACTIVITY. Complete
2019 R33 RFA-CA-18-003 SOPER, STEVEN ALLAN UNIVERSITY OF KANSAS LAWRENCE Increased Sensitivity of Minimal Residual Disease Monitoring using Peripheral Blood in Pediatric Patients with Acute Lymphoblastic Leukemia Active
2022 R33 RFA-CA-21-004 LEE, ABRAHAM P UNIVERSITY OF CALIFORNIA-IRVINE Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy Active
2002 R33 PAR-98-067 SHERRY, A. DEAN UNIVERSITY OF TEXAS DALLAS MRI AGENTS SENSITIVE TO BIOLOGICAL INDICATORS OF NEOPLAS Complete
2005 R33 RFA-CA-05-003 FU, XIANG-DONG UNIVERSITY OF CALIFORNIA SAN DIEGO TYPING THE TRANSCRIPTOME IN CANCER USING SPLICING ARRAY Complete
2015 R33 RFA-CA-14-004 CARON, MARC G. DUKE UNIVERSITY A CANCER RAINBOW MOUSE FOR SIMULTANEOUS ASSESSMENT OF MULTIPLE ONCOGENES Complete
2018 R33 RFA-CA-17-013 INCE, TAN A. UNIVERSITY OF MIAMI SCHOOL OF MEDICINE Live Tumor Culture Core and Tissue Specific Culture (TSC) System for Human Cancers Complete
2022 R33 CA21-004 NAEGLE, KRISTEN M UNIVERSITY OF VIRGINIA A synthetic toolkit for the recombinant production of tyrosine phosphorylated proteins and peptides Active
2010 R33 RFA-CA-09-007 CLAFFEY, KEVIN P. UNIVERSITY OF CONNECTICUT SCH OF MED/DNT DISCOVERY PLATFORM FOR CANCER ANTIGENS Complete

Pages